WO2014059649A1 - Lycopene microcapsule preparation method - Google Patents

Lycopene microcapsule preparation method Download PDF

Info

Publication number
WO2014059649A1
WO2014059649A1 PCT/CN2012/083157 CN2012083157W WO2014059649A1 WO 2014059649 A1 WO2014059649 A1 WO 2014059649A1 CN 2012083157 W CN2012083157 W CN 2012083157W WO 2014059649 A1 WO2014059649 A1 WO 2014059649A1
Authority
WO
WIPO (PCT)
Prior art keywords
lycopene
wall material
core material
preparation
oil phase
Prior art date
Application number
PCT/CN2012/083157
Other languages
French (fr)
Chinese (zh)
Inventor
冯敏
黄景苏
冯鹏
沈建
钱一帆
王连安
Original Assignee
南京中科药业有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南京中科药业有限公司 filed Critical 南京中科药业有限公司
Priority to PCT/CN2012/083157 priority Critical patent/WO2014059649A1/en
Publication of WO2014059649A1 publication Critical patent/WO2014059649A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Definitions

  • the invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a preparation method of a lycopene microcapsule.
  • Lycopene is a type of carotenoid that is widely found in plants such as tomatoes, watermelons, grapes, and carrots. Since lycopene does not have the physiological activity of vitamin A, its role has not been taken seriously. However, recent studies have shown that lycopene has superior performance to other carotenoids, such as 100 times more vitamin E, and more than twice as much as beta carotene. Lycopene can increase the body's immunity, inhibit cancer cell proliferation, reduce DNA loss, prevent low-density lipoprotein oxidation, and lower blood cholesterol levels, thus reducing the incidence of multiple diseases.
  • Lycopene is usually a dark red powder or an oily liquid.
  • the pure product is a needle-like deep red crystal. It is orange-yellow in a lower concentration solution and has a melting point of 174 ° C (trans) and can be burned.
  • lycopene is insoluble in water, and is insoluble in polar organic solvents such as methanol and ethanol. It is soluble in ether, petroleum ether, ethane, acetone, and easily soluble in chloroform, carbon disulfide, benzene, and oil. The higher the purity of lycopene, the more difficult it is to dissolve, and the solubility in various solvents increases with increasing temperature. Lycopene contains a large amount of unsaturated structure, which is easily degraded and isomerized by heat, light, oxygen, additives and the like during processing and storage, thereby reducing physiological activity.
  • lycopene In order to make full use of lycopene, lycopene can be embedded by microcapsule technology, which avoids direct contact between lycopene and the external environment, thereby improving stability.
  • microcapsule technology is a technique of coating liquid, solid or even gas (core material) into tiny particles by selecting a suitable film-forming material (wall material). After microcapsule treatment, the core material is not in direct contact with external environmental factors. , is effectively protected.
  • the existing process of microencapsulation of lycopene is difficult to ensure the long-term stability of the water solubility of lycopene microcapsules and the content of active ingredients.
  • the object of the present invention is to provide a preparation method of lycopene microcapsules which improves stability and can improve water solubility, thereby expanding the application field of lycopene microcapsules.
  • a method for preparing a lycopene microcapsule which comprises preparing a lycopene into a core material, and then subjecting the wall material to a homogeneous emulsification and spray drying step, wherein the wall material is prepared by the following method : In the weight ratio of 1: 1: 1: 1.2 ⁇ 1.6 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder as the wall material, add the above materials 3 ⁇ 5 times the amount of distilled water, heated to 40 ⁇ 45 °C, stirred to form a uniform suspension, which is the wall material.
  • the wall material is prepared by the following method: gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder as a wall material in a weight ratio of 1: 1: 1: 1.4, adding 4 times of distilled water of the above materials, heating to 45 ° C, stirring into a uniform suspension, that is, a wall material.
  • the core material is prepared by the following method: Dissolving 0.5 to 0.8 g of lycopene per 1 ml of salad oil, adding sucrose ester as an emulsifier, stirring uniformly to obtain a core material, lycopene and sucrose
  • the weight ratio of the ester is 10 to 14: 1;
  • the core material is prepared by the following method: 0.68 g of lycopene is dissolved in 1 ml of salad oil, and sucrose ester is added as an emulsifier, and the mixture is uniformly stirred.
  • the weight ratio of lycopene to sucrose ester was 8.5: 0.7.
  • the salad oil may be a common edible salad oil such as soybean salad oil, rapeseed salad oil, sunflower seed salad oil, rice bran salad oil or the like.
  • Broken Ganoderma lucidum spore powder should be selected from broken wall Ganoderma lucidum spore powder with a wall breaking rate greater than 95%.
  • the above homogeneous emulsification comprises the following steps: using a mixture of a core material and a wall material as an oil phase, slowly adding the oil phase while stirring in water, and the weight ratio of water to oil phase is 3 to 3.5:5 to 6, and then placed In the colloid mill, it is ground at 5000 to 10,000 rpm, and the grinding time is 20 to 40 min.
  • the homogeneous emulsification comprises the following steps: taking a mixture of the core material and the wall material as an oil phase, slowly adding the oil phase while stirring in water, the weight ratio of water to oil phase is 3:5, and then placing it in the colloid mill. Grinding was carried out at 6000 rpm, and the grinding time was 30 min.
  • the spray drying conditions are as follows: spray drying inlet air temperature is 170-180 ° C, outlet air temperature is 80-100 ° C, feed temperature is 45-50 ° C, and feed rate is 0.6-1.0 kg/min. , the blowing speed is 50 ⁇ 60 l/min.
  • the spray drying conditions are: spray drying inlet air temperature is 180 ° C, outlet air temperature is 80 to 100 ° C, feed temperature is 50 ° C, feed rate is 0.6 1.0 kg / min, and blowing speed is 50 to 60 liters. /minute.
  • the invention adopts a material which can form a film, meets the requirements of the national food additive, is non-toxic to the human body, and easily releases the core material in water, and adopts a suitable microencapsulation method to coat the lycopene in a minute and closed. Inside the membrane, it is converted into a manageable powder solid that protects sensitive lycopene from oxidation.
  • the wall material made of the new material of the invention can realize the slow release of the core material, prolong the action time of the functional factor, and the stability of the lycopene microcapsule is remarkably improved, and the core material prepared by using the formula of the invention is further improved.
  • the wall material used in the present invention is more easily coated.
  • the invention adopts a specific microcapsule technology to embed lycopene, and improves the stability of the active ingredient, and also improves the water solubility of the lycopene microcapsule, thereby expanding the application field.
  • the present invention will be further described below based on the embodiments, and the specific embodiments of the following embodiments are only more specifically The present invention is not limited to the contents of the following embodiments.
  • the lycopene, lycopene raw material described in the following examples is produced by Israel's Lycored Company with a purity of 98%; the salad oil is arowana soy salad oil, and the manufacturer is Shanghai Kerry Grain and Oil Industry Co., Ltd.; Sucrose ester (ie sucrose fatty acid ester) manufacturer is Liuzhou Aigfu Food Technology Co., Ltd.; Broken Ganoderma lucidum spore powder (breaking rate greater than 95%) Manufacturer is Nanjing Zhongke Pharmaceutical Co., Ltd.; Manufacturer of skim milk powder It is Heilongjiang Feihe Dairy Co., Ltd.; commercially available lycopene microcapsule 1 is produced by Parry Nutraceutical, India; and commercially available lycopene microcapsule 2 is produced by Israel's Lycored.
  • wall material preparation Take a weight ratio of 1: 1: 1: 1.4 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder (that is, wall material), add 4 times the amount of wall material raw water, heated to 45 °C, stir to make it a homogeneous suspension, this is the oil phase 8.
  • Homogeneous emulsification Slowly add a mixture of oil phase A and oil phase B while stirring in water.
  • the weight ratio of water to oil phase ie, the sum of oil phase A and oil phase B
  • the lycopene was uniformly dispersed in the wall material to obtain a homogenized emulsion.
  • the homogenized emulsion is spray-dried to obtain powdery lycopene microcapsules.
  • the spray drying control conditions are: spray drying inlet air temperature of 180 ° C, outlet air temperature of 90 ° C, feed temperature of 50 ° C, feed rate of 0.8 kg / min, blowing speed of 50 ⁇ 60 l / min .
  • the prepared lycopene microcapsules, the unmicroencapsulated lycopene raw materials, and the commercially available lycopene microcapsules 1 and the commercially available lycopene microcapsules 2 are respectively stored in a transparent sample bottle and sealed and stored at room temperature. At (20 ⁇ 5 °C), natural light was used to measure the lycopene content of the sample at intervals, and the retention rate was compared with the lycopene content of the sample before storage. Table 1 shows the results of determination of lycopene in different samples, wherein the method for determining lycopene content is in accordance with national standards: GB/T22249-2008.
  • lycopene microcapsules 20% 20.2% 20.1% 20.0% 19.6% 18.9% 17.2% Buy lycopene microcapsules 1 20% 19.8% 19.6% 17% 12.5% 10.6% 8.2%
  • the detection results of the lycopene microcapsules in this example are shown in Table 2, using the 2010 edition of the Chinese Pharmacopoeia appendix method three times. Parallel detection:
  • wall material preparation Take the weight ratio of 1: 1: 1: 1.2 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder (that is, wall material), add 3 times the amount of distilled water, wall material, heated to 45 °C, stir to make it a homogeneous suspension, this is the oil phase 8.
  • Homogeneous emulsification Slowly add a mixture of oil phase A and oil phase B while stirring in water. The weight ratio of water to oil phase is 3:5, and then placed in a colloid mill at 8000 rpm. Under the grinding, the grinding time is 25 min, that is, the lycopene is uniformly dispersed in the wall material to obtain a homogenized emulsion.
  • the homogenized emulsion is spray dried to obtain a powdery lycopene product.
  • the spray drying control conditions are: spray drying inlet air temperature of 180 ° C, outlet air temperature of 80 ° C, feed temperature of 45 ° C, feed rate of 0.6 kg / min, blowing speed of 50 ⁇ 60 l / min .
  • the time limit for disintegration of lycopene microcapsules in this example was tested by the 2010 edition of the Chinese Pharmacopoeia appendix method, and the average disintegration time was 46 min in three parallel tests.
  • Homogeneous emulsification Slowly add a mixture of oil phase A and oil phase B while stirring in water. The weight ratio of water to oil phase is 3.5:5, and then placed in a colloid mill at 5000 rpm. Under the grinding, the grinding time was 35 min, and lycopene was uniformly dispersed in the wall material to obtain a homogenized emulsion.
  • the homogenized emulsion is spray dried to obtain a powdery lycopene product.
  • the spray drying control conditions are: spray drying inlet air temperature of 170 ° C, outlet air temperature of 100 ° C, feed temperature of 50 ° C, feed rate of 1.0 kg / min, blowing speed of 50 ⁇ 60 l / min .
  • the stability test results of the lycopene content in the lycopene microcapsules of the present embodiment are shown in Table 4, and the detection methods are the same as the examples.
  • the time limit for disintegration of lycopene microcapsules in this example was tested by the 2010 edition of the Chinese Pharmacopoeia appendix method, and the average disintegration time was 48 min.

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Disclosed is a lycopene microcapsule preparation method, comprising the steps of: firstly preparing the lycopene into a core material, and then homogeneously emulsifying and spray-drying the core material and a wall material; the wall material is prepared from gelatin, sporoderm-broken ganoderma lucidum spore powder, cane sugar and skim milk powder in a weight ratio of 1: 1: 1: 1.2-1.6, and the core material is prepared from the lycopene, salad oil and sucrose ester. The present invention employs a specific microcapsule technique to embed the lycopene, and improves both stability and water solubility of the lycopene microcapsule, thus further expanding the application scope.

Description

番茄红素微胶嚢的制备方法  Preparation method of lycopene microcapsule
技术领域 Technical field
本发明属于中药技术领域, 具体涉及一种番茄红素微胶囊的制备方法。  The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a preparation method of a lycopene microcapsule.
背景技术 Background technique
番茄红素 (Lycopene) 是类胡萝卜素的一种, 广泛存在于番茄、 西瓜、 葡萄、 胡萝卜 等植物中。 由于番茄红素没有维生素 A的生理活性, 其作用一直未被重视。 但近年来的研 究表明, 番茄红素具有比其他胡萝卜素更为优越的性能, 如清除单线态氧的能力是维生素 E的 100倍, 是 β胡萝卜素的两倍多。 番茄红素能提高机体免疫力, 抑制癌细胞增殖, 减 少 DNA损失, 防止低密度脂蛋白氧化, 降低血液中的胆固醇含量, 因此可以减少多种疾 病的发生率。  Lycopene is a type of carotenoid that is widely found in plants such as tomatoes, watermelons, grapes, and carrots. Since lycopene does not have the physiological activity of vitamin A, its role has not been taken seriously. However, recent studies have shown that lycopene has superior performance to other carotenoids, such as 100 times more vitamin E, and more than twice as much as beta carotene. Lycopene can increase the body's immunity, inhibit cancer cell proliferation, reduce DNA loss, prevent low-density lipoprotein oxidation, and lower blood cholesterol levels, thus reducing the incidence of multiple diseases.
番茄红素通常为深红色粉末或油状液体, 纯品为针状深红色晶体, 在较低浓度溶液中 则呈橙黄色, 其熔点为 174°C (反式), 可燃烧。 作为脂肪烃, 番茄红素不溶于水, 难溶于 甲醇、 乙醇等极性有机溶剂, 可溶于乙醚、 石油醚、 乙烷、 丙酮, 易溶于氯仿、 二硫化碳、 苯、 油脂等。 番茄红素纯度越高, 溶解越困难, 在各种溶剂中的溶解度随着温度的上升而 增大。 番茄红素含有大量不饱和结构, 在加工储藏过程中容易受热、 光、 氧气、 添加剂等 因素影响而发生降解和异构化, 从而降低生理活性。  Lycopene is usually a dark red powder or an oily liquid. The pure product is a needle-like deep red crystal. It is orange-yellow in a lower concentration solution and has a melting point of 174 ° C (trans) and can be burned. As an aliphatic hydrocarbon, lycopene is insoluble in water, and is insoluble in polar organic solvents such as methanol and ethanol. It is soluble in ether, petroleum ether, ethane, acetone, and easily soluble in chloroform, carbon disulfide, benzene, and oil. The higher the purity of lycopene, the more difficult it is to dissolve, and the solubility in various solvents increases with increasing temperature. Lycopene contains a large amount of unsaturated structure, which is easily degraded and isomerized by heat, light, oxygen, additives and the like during processing and storage, thereby reducing physiological activity.
为了充分利用番茄红素, 可采用微胶囊技术将番茄红素包埋, 避免了番茄红素与外界 环境的直接接触, 进而提高稳定性。 所谓微胶囊技术, 就是通过选用合适的成膜材料 (壁 材) 将液体、 固体甚至是气体 (芯材) 包覆形成微小颗粒的技术, 微胶囊处理后, 芯材不 与外界环境因素直接接触, 得到有效保护。 但现有的番茄红素微胶囊化的工艺难以保证番 茄红素微胶囊的水溶性及其有效成分含量的长期稳定性。  In order to make full use of lycopene, lycopene can be embedded by microcapsule technology, which avoids direct contact between lycopene and the external environment, thereby improving stability. The so-called microcapsule technology is a technique of coating liquid, solid or even gas (core material) into tiny particles by selecting a suitable film-forming material (wall material). After microcapsule treatment, the core material is not in direct contact with external environmental factors. , is effectively protected. However, the existing process of microencapsulation of lycopene is difficult to ensure the long-term stability of the water solubility of lycopene microcapsules and the content of active ingredients.
发明内容 Summary of the invention
本发明的目的是提供一种提高稳定性并能改善水溶性的番茄红素微胶囊的制备方法, 进而扩大番茄红素微胶囊的应用领域。  SUMMARY OF THE INVENTION The object of the present invention is to provide a preparation method of lycopene microcapsules which improves stability and can improve water solubility, thereby expanding the application field of lycopene microcapsules.
本发明的目的是通过以下方式实现的:  The object of the invention is achieved in the following ways:
一种番茄红素微胶囊的制备方法, 该方法主要将番茄红素制备成芯材后, 再与壁材经 过均质乳化及喷雾干燥步骤, 其中, 所述的壁材是由以下方法制备得到的: 以重量比为 1 : 1: 1: 1.2〜1.6 的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉为壁材原材料, 加入上述材料 3〜5 倍量蒸馏水, 加热至 40〜45°C, 搅拌成为均匀的混悬液, 即为壁材。 优选壁材由以 下方法制备得到: 以重量比为 1 : 1: 1: 1.4的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉为 壁材原材料, 加入上述材料 4倍量蒸馏水, 加热至 45°C, 搅拌成为均匀的混悬液, 即为壁 材。 A method for preparing a lycopene microcapsule, which comprises preparing a lycopene into a core material, and then subjecting the wall material to a homogeneous emulsification and spray drying step, wherein the wall material is prepared by the following method : In the weight ratio of 1: 1: 1: 1.2~1.6 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder as the wall material, add the above materials 3~5 times the amount of distilled water, heated to 40~45 °C, stirred to form a uniform suspension, which is the wall material. Preferably, the wall material is prepared by the following method: gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder as a wall material in a weight ratio of 1: 1: 1: 1.4, adding 4 times of distilled water of the above materials, heating to 45 ° C, stirring into a uniform suspension, that is, a wall material.
所述的芯材是由以下方法制备得到的: 将每 0.5〜0.8g番茄红素溶于 lml的色拉油中, 并加入蔗糖酯作乳化剂, 搅拌均匀即为芯材, 番茄红素与蔗糖酯的重量比为 10〜14: 1; 优选芯材是由以下方法制备得到的: 将每 0.68g番茄红素溶于 lml的色拉油中, 并加入蔗 糖酯作乳化剂, 搅拌均匀即为芯材, 番茄红素与蔗糖酯的重量比为 8.5: 0.7。  The core material is prepared by the following method: Dissolving 0.5 to 0.8 g of lycopene per 1 ml of salad oil, adding sucrose ester as an emulsifier, stirring uniformly to obtain a core material, lycopene and sucrose The weight ratio of the ester is 10 to 14: 1; Preferably, the core material is prepared by the following method: 0.68 g of lycopene is dissolved in 1 ml of salad oil, and sucrose ester is added as an emulsifier, and the mixture is uniformly stirred. The weight ratio of lycopene to sucrose ester was 8.5: 0.7.
其中, 所述的色拉油可以为大豆色拉油、 菜籽色拉油、 葵花籽色拉油、 米糠色拉 油等常用食用色拉油。 破壁灵芝孢子粉宜选破壁率大于 95%的破壁灵芝孢子粉。  Wherein, the salad oil may be a common edible salad oil such as soybean salad oil, rapeseed salad oil, sunflower seed salad oil, rice bran salad oil or the like. Broken Ganoderma lucidum spore powder should be selected from broken wall Ganoderma lucidum spore powder with a wall breaking rate greater than 95%.
上述均质乳化包括以下步骤: 以芯材与壁材的混合液为油相, 在水中边搅拌边缓缓加 入油相, 水与油相重量比为 3〜3.5:5〜6, 再置于胶体磨中, 在 5000〜10000转 /分钟条件 下研磨, 研磨时间为 20〜40min。  The above homogeneous emulsification comprises the following steps: using a mixture of a core material and a wall material as an oil phase, slowly adding the oil phase while stirring in water, and the weight ratio of water to oil phase is 3 to 3.5:5 to 6, and then placed In the colloid mill, it is ground at 5000 to 10,000 rpm, and the grinding time is 20 to 40 min.
优选均质乳化包括以下步骤: 以芯材与壁材的混合液为油相, 在水中边搅拌边缓缓加 入油相, 水与油相重量比为 3:5, 再置于胶体磨中, 在 6000转 /分钟条件下研磨, 研磨时间 为 30min。  Preferably, the homogeneous emulsification comprises the following steps: taking a mixture of the core material and the wall material as an oil phase, slowly adding the oil phase while stirring in water, the weight ratio of water to oil phase is 3:5, and then placing it in the colloid mill. Grinding was carried out at 6000 rpm, and the grinding time was 30 min.
所述的喷雾干燥条件为: 喷雾干燥进风温度为 170~180°C, 出风温度为 80~100°C, 进 料温度为 45~50°C, 进料速度为 0.6~1.0千克 /分钟, 吹风速度 50~60升 /分钟。 优选喷雾干 燥条件为: 喷雾干燥进风温度为 180°C, 出风温度为 80~100°C, 进料温度为 50°C, 进料速 度为 0.6 1.0千克 /分钟, 吹风速度 50~60升 /分钟。  The spray drying conditions are as follows: spray drying inlet air temperature is 170-180 ° C, outlet air temperature is 80-100 ° C, feed temperature is 45-50 ° C, and feed rate is 0.6-1.0 kg/min. , the blowing speed is 50~60 l/min. Preferably, the spray drying conditions are: spray drying inlet air temperature is 180 ° C, outlet air temperature is 80 to 100 ° C, feed temperature is 50 ° C, feed rate is 0.6 1.0 kg / min, and blowing speed is 50 to 60 liters. /minute.
与现有技术比较本发明的有益效果:  Compare the advantages of the present invention with the prior art:
本发明选用可成膜的、符合国家食品添加剂要求、对人体无毒、遇水易释放芯材的物 质作为壁材, 并采用适宜的微胶囊化方法将番茄红素包覆在一微小且封闭的膜内, 使之转 化成易处理的粉末固体, 保护敏感的番茄红素, 防止其被氧化。 特别是本发明采用新材料 制作的壁材可以实现芯材的缓慢释放, 延长功能因子作用时间, 使番茄红素微胶囊的稳定 性得到显著的提高, 而且, 采用本发明配方制备得到的芯材使得本发明所用壁材更易将其 包覆。 本发明采用特定的微胶囊技术包埋番茄红素, 在提高有效成分的稳定性的同时, 还 能改善番茄红素微胶囊的水溶性, 进而扩大应用领域。  The invention adopts a material which can form a film, meets the requirements of the national food additive, is non-toxic to the human body, and easily releases the core material in water, and adopts a suitable microencapsulation method to coat the lycopene in a minute and closed. Inside the membrane, it is converted into a manageable powder solid that protects sensitive lycopene from oxidation. In particular, the wall material made of the new material of the invention can realize the slow release of the core material, prolong the action time of the functional factor, and the stability of the lycopene microcapsule is remarkably improved, and the core material prepared by using the formula of the invention is further improved. The wall material used in the present invention is more easily coated. The invention adopts a specific microcapsule technology to embed lycopene, and improves the stability of the active ingredient, and also improves the water solubility of the lycopene microcapsule, thereby expanding the application field.
具体实fc^: Specific real fc^:
下面根据实施例对本发明作进一步描述, 以下实施例的具体实施方案只是更具体地说 明本发明, 本发明并不限于以下实施例的内容。 以下实施例所述的番茄红素即番茄红素原 料, 为以色列乐康瑞德 (Lycored) 公司生产, 纯度为 98% ; 色拉油为金龙鱼大豆色拉油, 生产厂家为上海嘉里粮油工业有限公司; 蔗糖酯 (即蔗糖脂肪酸酯) 生产厂家为柳州爱格 富食品科技有限公司; 破壁灵芝孢子粉 (破壁率大于 95% ) 生产厂家为南京中科药业有限 公司; 脱脂奶粉的生产厂家为黑龙江飞鹤乳业有限公司; 市购番茄红素微胶囊 1 为印度 Parry Nutraceutical公司生产; 市购番茄红素微胶囊 2 为以色列乐康瑞德 (Lycored) 公司 生产。 The present invention will be further described below based on the embodiments, and the specific embodiments of the following embodiments are only more specifically The present invention is not limited to the contents of the following embodiments. The lycopene, lycopene raw material described in the following examples, is produced by Israel's Lycored Company with a purity of 98%; the salad oil is arowana soy salad oil, and the manufacturer is Shanghai Kerry Grain and Oil Industry Co., Ltd.; Sucrose ester (ie sucrose fatty acid ester) manufacturer is Liuzhou Aigfu Food Technology Co., Ltd.; Broken Ganoderma lucidum spore powder (breaking rate greater than 95%) Manufacturer is Nanjing Zhongke Pharmaceutical Co., Ltd.; Manufacturer of skim milk powder It is Heilongjiang Feihe Dairy Co., Ltd.; commercially available lycopene microcapsule 1 is produced by Parry Nutraceutical, India; and commercially available lycopene microcapsule 2 is produced by Israel's Lycored.
实施例 1  Example 1
1、 芯材制备: 将 8.5g番茄红素加入 12.5ml的色拉油中, 并添加 0.7g蔗糖酯作乳化剂, 搅 拌均匀, 此为油相八。  1. Preparation of core material: 8.5 g of lycopene was added to 12.5 ml of salad oil, and 0.7 g of sucrose ester was added as an emulsifier, and the mixture was uniformly stirred. This was oil phase eight.
2、 壁材制备: 取重量比例为 1 : 1: 1: 1.4的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉(即 为壁材原材料), 加入壁材原材料 4倍量蒸馏水, 加热至 45°C, 搅拌使之成为均匀的混 悬液, 此为油相8。  2, wall material preparation: Take a weight ratio of 1: 1: 1: 1.4 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder (that is, wall material), add 4 times the amount of wall material raw water, heated to 45 °C, stir to make it a homogeneous suspension, this is the oil phase 8.
3、 均质乳化: 在水中边搅拌边缓缓加入油相 A和油相 B的混合液, 水与油相 (即油相 A 与油相 B之和) 的重量比为 3:5, 再置于胶体磨中, 在 6000转 /分钟条件下研磨, 研磨 时间为 30min, 将番茄红素均匀地分散于壁材中, 得到均质后的乳化液。  3. Homogeneous emulsification: Slowly add a mixture of oil phase A and oil phase B while stirring in water. The weight ratio of water to oil phase (ie, the sum of oil phase A and oil phase B) is 3:5. It was placed in a colloid mill, ground at 6000 rpm, and the grinding time was 30 min. The lycopene was uniformly dispersed in the wall material to obtain a homogenized emulsion.
将均质后的乳化液经喷雾干燥得到粉末状番茄红素微胶囊。 喷雾干燥的控制条件为: 喷雾干燥进风温度为 180°C, 出风温度为 90°C, 进料温度为 50°C, 进料速度为 0.8千克 / 分钟, 吹风速度 50~60升 /分钟。  The homogenized emulsion is spray-dried to obtain powdery lycopene microcapsules. The spray drying control conditions are: spray drying inlet air temperature of 180 ° C, outlet air temperature of 90 ° C, feed temperature of 50 ° C, feed rate of 0.8 kg / min, blowing speed of 50 ~ 60 l / min .
本实施例番茄红素微胶囊含量的稳定性试验及检测结果:  The stability test and detection result of the lycopene microcapsule content of the present embodiment:
将制备好的番茄红素微胶囊、 未微胶囊化的番茄红素原料及市购番茄红素微胶囊 1、 市购番茄红素微胶囊 2分别装于透明的样品瓶中密封贮藏, 在室温 (20 ± 5°C ) 下采用自 然光照射, 每隔一段时间取样测定样品中番茄红素的含量, 与贮藏前样品中番茄红素的含 量相比得保留率。 表 1为不同样品中番茄红素的含量测定结果, 其中, 番茄红素含量测定 方法按照国家标准: GB/T22249-2008。  The prepared lycopene microcapsules, the unmicroencapsulated lycopene raw materials, and the commercially available lycopene microcapsules 1 and the commercially available lycopene microcapsules 2 are respectively stored in a transparent sample bottle and sealed and stored at room temperature. At (20 ± 5 °C), natural light was used to measure the lycopene content of the sample at intervals, and the retention rate was compared with the lycopene content of the sample before storage. Table 1 shows the results of determination of lycopene in different samples, wherein the method for determining lycopene content is in accordance with national standards: GB/T22249-2008.
表 1  Table 1
起始 1周 2周 4周 24周 48周 96周 番茄红素原料 98% 20% 3.5% 0 0 0 0 本实施例番茄红素微胶囊 20% 20.2% 20.1% 20.0% 19.6% 18.9% 17.2% 市购番茄红素微胶囊 1 20% 19.8% 19.6% 17% 12.5% 10.6% 8.2% 市购番茄红素微胶囊 2 20% 19.6% 19.2% 16.3% 11.4% 8.9% 7.0% 本实施例番茄红素微胶囊崩解时限检测结果见表 2, 采用 2010版 《中国药典》 附录 方法进行三次平行检测: Starting 1 week 2 weeks 4 weeks 24 weeks 48 weeks 96 weeks lycopene raw material 98% 20% 3.5% 0 0 0 0 This embodiment lycopene microcapsules 20% 20.2% 20.1% 20.0% 19.6% 18.9% 17.2% Buy lycopene microcapsules 1 20% 19.8% 19.6% 17% 12.5% 10.6% 8.2% Commercially available lycopene microcapsules 2 20% 19.6% 19.2% 16.3% 11.4% 8.9% 7.0% The detection results of the lycopene microcapsules in this example are shown in Table 2, using the 2010 edition of the Chinese Pharmacopoeia appendix method three times. Parallel detection:
表 2  Table 2
Figure imgf000005_0001
Figure imgf000005_0001
实施例 2  Example 2
1、 芯材制备: 将 8g番茄红素加入 12.5ml的色拉油中, 并添加 0.7g蔗糖酯作乳化剂, 搅 拌均匀, 此为油相八。  1. Preparation of core material: 8 g of lycopene was added to 12.5 ml of salad oil, and 0.7 g of sucrose ester was added as an emulsifier, and the mixture was uniformly stirred. This was oil phase eight.
2、 壁材制备: 取重量比例为 1 : 1: 1: 1.2的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉(即 为壁材原材料), 加入壁材原材料 3倍量蒸馏水, 加热至 45°C, 搅拌使之成为均匀的混 悬液, 此为油相8。  2, wall material preparation: Take the weight ratio of 1: 1: 1: 1.2 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder (that is, wall material), add 3 times the amount of distilled water, wall material, heated to 45 °C, stir to make it a homogeneous suspension, this is the oil phase 8.
3、 均质乳化: 在水中边搅拌边缓缓加入油相 A和油相 B的混合液, 水与油相的重量比为 3:5, 再置于胶体磨中, 在 8000转 /分钟条件下研磨, 研磨时间为 25min, 即将番茄红素 均匀地分散于壁材中, 得到均质后的乳化液。  3. Homogeneous emulsification: Slowly add a mixture of oil phase A and oil phase B while stirring in water. The weight ratio of water to oil phase is 3:5, and then placed in a colloid mill at 8000 rpm. Under the grinding, the grinding time is 25 min, that is, the lycopene is uniformly dispersed in the wall material to obtain a homogenized emulsion.
均质后的乳化液经喷雾干燥得到粉末状番茄红素产品。 喷雾干燥的控制条件为: 喷雾 干燥进风温度为 180°C, 出风温度为 80°C, 进料温度为 45°C, 进料速度为 0.6千克 /分钟, 吹风速度 50~60升 /分钟。  The homogenized emulsion is spray dried to obtain a powdery lycopene product. The spray drying control conditions are: spray drying inlet air temperature of 180 ° C, outlet air temperature of 80 ° C, feed temperature of 45 ° C, feed rate of 0.6 kg / min, blowing speed of 50 ~ 60 l / min .
本实施例番茄红素微胶囊中蕃茄红素含量的稳定性检测结果见表 3, 检测方法同实施 例 1 :  The stability test results of the lycopene content in the lycopene microcapsules of the present embodiment are shown in Table 3, and the detection method is the same as in the embodiment 1:
表 3  table 3
Figure imgf000005_0002
Figure imgf000005_0002
本实施例番茄红素微胶囊崩解时限检测采用 2010版 《中国药典》 附录方法进行, 三 次平行检测得到平均崩解时间为 46min。  The time limit for disintegration of lycopene microcapsules in this example was tested by the 2010 edition of the Chinese Pharmacopoeia appendix method, and the average disintegration time was 46 min in three parallel tests.
实施例 3  Example 3
1、 芯材制备: 将 9g番茄红素加入 12.5ml的色拉油中, 并添加 0.7g蔗糖酯作乳化剂, 搅 拌均匀, 此为油相八。 2、 壁材制备: 取重量比例为 1 : 1: 1: 1.6的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉(即 为壁材原材料), 加入壁材原材料 5倍量蒸馏水, 加热至 40°C, 搅拌使之成为均匀的混 悬液, 此为油相8。 1. Preparation of core material: 9 g of lycopene was added to 12.5 ml of salad oil, and 0.7 g of sucrose ester was added as an emulsifier, and the mixture was uniformly stirred, which was oil phase eight. 2, wall material preparation: Take a weight ratio of 1: 1: 1: 1.6 gelatin, broken ganoderma lucidum spore powder, sucrose, skim milk powder (that is, wall material), add 5 times the amount of distilled water, wall material, heated to 40 °C, stir to make it a homogeneous suspension, this is the oil phase 8.
3、 均质乳化: 在水中边搅拌边缓缓加入油相 A和油相 B的混合液, 水与油相的重量比为 3.5:5, 再置于胶体磨中, 在 5000转 /分钟条件下研磨, 研磨时间为 35min, 将番茄红素 均匀地分散于壁材中, 得到均质后的乳化液。  3. Homogeneous emulsification: Slowly add a mixture of oil phase A and oil phase B while stirring in water. The weight ratio of water to oil phase is 3.5:5, and then placed in a colloid mill at 5000 rpm. Under the grinding, the grinding time was 35 min, and lycopene was uniformly dispersed in the wall material to obtain a homogenized emulsion.
均质后的乳化液经喷雾干燥得到粉末状番茄红素产品。 喷雾干燥的控制条件为: 喷雾 干燥进风温度为 170°C, 出风温度为 100°C, 进料温度为 50°C, 进料速度为 1.0千克 /分钟, 吹风速度 50~60升 /分钟。  The homogenized emulsion is spray dried to obtain a powdery lycopene product. The spray drying control conditions are: spray drying inlet air temperature of 170 ° C, outlet air temperature of 100 ° C, feed temperature of 50 ° C, feed rate of 1.0 kg / min, blowing speed of 50 ~ 60 l / min .
本实施例番茄红素微胶囊中蕃茄红素含量的稳定性检测结果见表 4,检测方法同实施例 The stability test results of the lycopene content in the lycopene microcapsules of the present embodiment are shown in Table 4, and the detection methods are the same as the examples.
1: 1:
表 4  Table 4
Figure imgf000006_0001
Figure imgf000006_0001
本实施例番茄红素微胶囊崩解时限检测采用 2010版 《中国药典》 附录方法进行, 次平行检测得到平均崩解时间为 48min。  The time limit for disintegration of lycopene microcapsules in this example was tested by the 2010 edition of the Chinese Pharmacopoeia appendix method, and the average disintegration time was 48 min.

Claims

权 利 要 求 书 claims
1、 一种番茄红素微胶囊的制备方法, 该方法主要将番茄红素制备成芯材后, 再与壁材经 过均质乳化及喷雾干燥, 其特征在于所述的壁材是由以下方法制备得到的: 以重量比为 1 : 1: 1: 1.2〜1.6 的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉为壁材原材料, 加入上述材料 3〜5倍量蒸馏水, 加热至 40〜45°C, 搅拌成为均匀的混悬液, 即为壁材。 1. A method for preparing lycopene microcapsules. This method mainly prepares lycopene into a core material, and then homogeneously emulsifies and spray-dries it with the wall material. It is characterized in that the wall material is made by the following method Prepared: Gelatin, broken Ganoderma spore powder, sucrose, and skimmed milk powder with a weight ratio of 1:1:1:1.2~1.6 are used as wall material raw materials, add 3~5 times the amount of distilled water to the above materials, and heat to 40~45 °C, stir to form a uniform suspension, which is the wall material.
2、 根据权利要求 1所述的番茄红素微胶囊的制备方法, 其特征在于所述的壁材是由以下 方法制备得到的: 以重量比为 1 : 1: 1: 1.4的明胶、 破壁灵芝孢子粉、 蔗糖、 脱脂奶粉为 壁材原材料, 加入上述材料 4倍量蒸馏水, 加热至 45°C, 搅拌成为均匀的混悬液, 即为壁 材。 2. The preparation method of lycopene microcapsules according to claim 1, characterized in that the wall material is prepared by the following method: gelatin and broken wall in a weight ratio of 1:1:1:1.4 Ganoderma spore powder, sucrose, and skimmed milk powder are the raw materials for the wall material. Add 4 times the amount of distilled water to the above materials, heat to 45°C, and stir to form a uniform suspension, which is the wall material.
3、 根据权利要求 1所述的番茄红素微胶囊的制备方法, 其特征在于所述的芯材是由以下 方法制备得到的: 将每 0.5〜0.8g番茄红素溶于 lml的色拉油中, 并加入蔗糖酯作乳化剂, 番茄红素与蔗糖酯的重量比为 10〜14: 1, 即为芯材。 3. The preparation method of lycopene microcapsules according to claim 1, characterized in that the core material is prepared by the following method: Dissolve every 0.5~0.8g lycopene in 1ml of salad oil , and add sucrose ester as an emulsifier. The weight ratio of lycopene to sucrose ester is 10 to 14: 1, which is the core material.
4、 根据权利要求 3所述的番茄红素微胶囊的制备方法, 其特征在于所述的芯材是由以下 方法制备得到的: 将每 0.68g番茄红素溶于 lml的色拉油中, 并加入蔗糖酯作乳化剂, 番 茄红素与蔗糖酯的重量比为 8.5: 0.7, 即为芯材。 4. The preparation method of lycopene microcapsules according to claim 3, characterized in that the core material is prepared by the following method: Dissolve 0.68g of lycopene in 1ml of salad oil, and Add sucrose ester as emulsifier, and the weight ratio of lycopene to sucrose ester is 8.5:0.7, which is the core material.
5、 根据权利要求 1所述的番茄红素微胶囊的制备方法, 其特征在于所述的均质乳化包括 以下步骤: 以芯材与壁材的混合液为油相, 在水中边搅拌边缓缓加入油相, 水与油相重量 比为 3〜3.5:5〜6,再置于胶体磨中,在 5000〜10000转 /分钟条件下研磨,研磨时间为 20〜 40min。 5. The preparation method of lycopene microcapsules according to claim 1, characterized in that the homogeneous emulsification includes the following steps: using the mixture of core material and wall material as the oil phase, stirring and slowing down in water. Slowly add the oil phase, the weight ratio of water to oil phase is 3~3.5:5~6, then place it in a colloid mill, grind at 5000~10000 rpm, the grinding time is 20~40min.
6、 根据权利要求 5所述的番茄红素微胶囊的制备方法, 其特征在于所述的均质乳化包括 以下步骤: 以芯材与壁材的混合液为油相, 在水中边搅拌边缓缓加入油相, 水与油相重量 比为 3:5, 再置于胶体磨中, 在 6000转 /分钟条件下研磨, 研磨时间为 30min。 6. The preparation method of lycopene microcapsules according to claim 5, characterized in that the homogeneous emulsification includes the following steps: using the mixture of core material and wall material as the oil phase, stirring and slowing down in water. Slowly add the oil phase, the weight ratio of water to oil phase is 3:5, then place it in a colloid mill and grind at 6000 rpm for 30 minutes.
7、 根据权利要求 1所述的番茄红素微胶囊的制备方法, 其特征在于所述的喷雾干燥条件 为: 喷雾干燥进风温度为 170~180°C, 出风温度为 80~100°C, 进料温度为 45~50°C, 进料 速度为 0.6~1.0千克 /分钟, 吹风速度 50~60升 /分钟。 7. The preparation method of lycopene microcapsules according to claim 1, characterized in that the spray drying conditions are: the spray drying air inlet temperature is 170~180°C, and the air outlet temperature is 80~100°C , the feeding temperature is 45~50°C, the feeding speed is 0.6~1.0kg/min, and the blowing speed is 50~60 liters/min.
8、 根据权利要求 7所述的番茄红素微胶囊的制备方法, 其特征在于所述的喷雾干燥条件 为: 喷雾干燥进风温度为 180°C, 出风温度为 80~100°C, 进料温度为 50°C, 进料速度为 0.6-1.0千克 /分钟, 吹风速度 50~60升 /分钟。 8. The preparation method of lycopene microcapsules according to claim 7, characterized in that the spray drying conditions are: the spray drying air inlet temperature is 180°C, the air outlet temperature is 80~100°C, The material temperature is 50°C, the feeding speed is 0.6-1.0 kg/min, and the blowing speed is 50~60 liters/min.
PCT/CN2012/083157 2012-10-18 2012-10-18 Lycopene microcapsule preparation method WO2014059649A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/083157 WO2014059649A1 (en) 2012-10-18 2012-10-18 Lycopene microcapsule preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2012/083157 WO2014059649A1 (en) 2012-10-18 2012-10-18 Lycopene microcapsule preparation method

Publications (1)

Publication Number Publication Date
WO2014059649A1 true WO2014059649A1 (en) 2014-04-24

Family

ID=50487465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/083157 WO2014059649A1 (en) 2012-10-18 2012-10-18 Lycopene microcapsule preparation method

Country Status (1)

Country Link
WO (1) WO2014059649A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108096216A (en) * 2018-01-09 2018-06-01 皖西学院 A kind of preparation method for the full active component combination micro-capsule of ganoderma lucidum for improving immunity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015342A (en) * 2007-02-08 2007-08-15 上海交通大学 Preparation method of lycopersicin microcapsule
CN101803739A (en) * 2010-01-20 2010-08-18 陈恒雷 Production method of lycopene microcapsule
CN102860996A (en) * 2012-10-18 2013-01-09 南京中科药业有限公司 Method for preparing lycoypene microcapsule

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015342A (en) * 2007-02-08 2007-08-15 上海交通大学 Preparation method of lycopersicin microcapsule
CN101803739A (en) * 2010-01-20 2010-08-18 陈恒雷 Production method of lycopene microcapsule
CN102860996A (en) * 2012-10-18 2013-01-09 南京中科药业有限公司 Method for preparing lycoypene microcapsule

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BAN, JUNFENG ET AL.: "The impact on stability of lycopene in the micro particulate system", CEREALS & OILS, 31 January 2012 (2012-01-31), pages 46 - 48 *
SHU, BO ET AL.: "Study on microencapsulation of lycopene by spray-drying", JOURNAL OF FOOD ENGINEERING, vol. 76, 2006, pages 664 - 669, XP025028751, DOI: doi:10.1016/j.jfoodeng.2005.05.062 *
SILVA, D.F. ET AL.: "Microencapsulation of lycopene by gelatin-pectin complex coacervation", JOURNAL OF FOOD PROCESSING AND PRESERVATION, vol. 36, 21 September 2011 (2011-09-21), pages 185 - 190 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108096216A (en) * 2018-01-09 2018-06-01 皖西学院 A kind of preparation method for the full active component combination micro-capsule of ganoderma lucidum for improving immunity

Similar Documents

Publication Publication Date Title
CN102860996B (en) Method for preparing lycoypene microcapsule
Anese et al. Effect of ultrasound treatments of tomato pulp on microstructure and lycopene in vitro bioaccessibility
Zhang et al. Influence of anionic alginate and cationic chitosan on physicochemical stability and carotenoids bioaccessibility of soy protein isolate-stabilized emulsions
CN103406079B (en) Do not use the method that organic solvent prepares cold water dispersion type carotenoid micro-capsule powder
CN107307403B (en) Astaxanthin micro-nano solid preparation
Chen et al. Gypenosides as natural emulsifiers for oil-in-water nanoemulsions loaded with astaxanthin: Insights of formulation, stability and release properties
Arana et al. Solid lipid nanoparticles for delivery of Calendula officinalis extract
RU2598748C1 (en) Method of producing nanocapsules of adaptogens in sodium alginate
Moreno et al. Storage stability and simulated gastrointestinal release of spray dried grape marc phenolics
Feng et al. Physicochemical properties and in vitro bioaccessibility of lutein loaded emulsions stabilized by corn fiber gums
Wu et al. Liquid antisolvent precipitation: An effective method for ocular targeting of lutein esters
Wang et al. Effects of lutein particle size in embedding emulsions on encapsulation efficiency, storage stability, and dissolution rate of microencapsules through spray drying
Zhang et al. Fabrication of astaxanthin-enriched colon-targeted alginate microspheres and its beneficial effect on dextran sulfate sodium-induced ulcerative colitis in mice
CN105832569A (en) Water-dispersible transparent astaxanthin emulsion and preparation method
NO336747B1 (en) Triterpene-containing oleogel forming agent, triterpene-containing oleogel and method for preparing a triterpene-containing oleogel, as well as the use of highly dispersed triterpene as a thickener in a liquid.
Lim et al. Spray drying of high hydrophilic solids emulsions with layered interface and trehalose-maltodextrin as glass formers for carotenoids stabilization
CN104257632A (en) Solid lipid nanometer particle for astaxanthin and preparation method of solid lipid nanometer particle
CN108185022A (en) A kind of emulsion oil-in-water of high oxidation stability and preparation method thereof
WO2019109346A1 (en) Lycopene micro-capsule powder and preparation method therefor
WO2019070885A1 (en) Methods of preparing solulizable, encapsulated plant-based compositions, products based on same
Gómez-Guillén et al. Bioactive and technological functionality of a lipid extract from shrimp (L. vannamei) cephalothorax
WO2022222683A1 (en) Coenzyme q10 microemulsion, preparation method therefor and use thereof
WO2019080193A1 (en) Liposome encapsulating free astaxanthin and preparation method therefor
CN108882729A (en) The Nano capsule of fat-soluble active ingredient, manufacture and purposes
WO2014059649A1 (en) Lycopene microcapsule preparation method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12886889

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12886889

Country of ref document: EP

Kind code of ref document: A1